{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T09:59:43Z","timestamp":1766138383202,"version":"3.44.0"},"reference-count":17,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales Pharmaceutiques Fran\u00e7aises"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.pharma.2023.07.008","type":"journal-article","created":{"date-parts":[[2023,8,2]],"date-time":"2023-08-02T11:23:31Z","timestamp":1690975411000},"page":"53-63","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Separation and quantification of azelnidipine and chlorthalidone in a synthetic mixture using optimized HPTLC method"],"prefix":"10.1016","volume":"82","author":[{"given":"Juhi","family":"Raimalani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5484-874X","authenticated-orcid":false,"given":"Rajendra","family":"Kotadiya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pharma.2023.07.008_bib0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/14737167.2020.1734456","article-title":"Fixed dose drug combinations\u00a0\u2013\u00a0are they pharmacoeconomically sound?. Findings and implications especially for lower-and middle-income countries","volume":"20","author":"Godman","year":"2020","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"key":"10.1016\/j.pharma.2023.07.008_bib0095","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1001\/jamainternmed.2019.7454","article-title":"Comparison of cardiovascular and safety outcomes of chlorthalidone vs. hydrochlorothiazide to treat hypertension","volume":"180","author":"Hripcsak","year":"2020","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.pharma.2023.07.008_bib0100","doi-asserted-by":"crossref","first-page":"663","DOI":"10.7326\/M16-1208","article-title":"Chlorthalidone versus hydrochlorothiazide: a new kind of veterans\u2019 affairs cooperative study","volume":"165","author":"Lederle","year":"2016","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.pharma.2023.07.008_bib0105","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1080\/10641963.2019.1693586","article-title":"Efficacy and safety of a combination antihypertensive drug (olmesartan plus azelnidipine):\u201cIssues with hypertension studies in real-world practice\u201d","volume":"42","author":"Okamura","year":"2020","journal-title":"Clin Exp Hypertens"},{"key":"10.1016\/j.pharma.2023.07.008_bib0110","doi-asserted-by":"crossref","first-page":"18014","DOI":"10.1038\/nrdp.2018.14","article-title":"Hypertension (primer)","volume":"4","author":"Oparil","year":"2018","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.pharma.2023.07.008_bib0115","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1291\/hypres.29.767","article-title":"Efficacy of azelnidipine on home blood pressure and pulse rate in patients with essential hypertension: comparison with amlodipine","volume":"29","author":"Yamagishi","year":"2006","journal-title":"Hypertens Res"},{"key":"10.1016\/j.pharma.2023.07.008_bib0120","doi-asserted-by":"crossref","first-page":"983","DOI":"10.2174\/1573412916999200704144231","article-title":"Analytical methods practiced to quantitation of rifampicin: A captious survey","volume":"17","author":"Kotadiya","year":"2021","journal-title":"Curr Pharm Anal"},{"key":"10.1016\/j.pharma.2023.07.008_bib0125","doi-asserted-by":"crossref","first-page":"66","DOI":"10.2174\/1573412919666221025124218","article-title":"Progress in quantitative methods for azelnidipine and chlorthalidone: an analytical basis for a recently approved FDC","volume":"19","author":"Raimalani","year":"2023","journal-title":"Curr Pharm Anal"},{"key":"10.1016\/j.pharma.2023.07.008_bib0130","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1093\/jaoacint\/qsac082","article-title":"Analytical quality by design-based robust RP-HPLC method for quantitative estimation of pregabalin and etoricoxib in fixed-dose combination tablet formulation","volume":"105","author":"Shah","year":"2022","journal-title":"J AOAC Int"},{"key":"10.1016\/j.pharma.2023.07.008_bib0135","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.jtusci.2015.11.004","article-title":"Development and validation of an HPTLC method for the simultaneous estimation of clonazepam and paroxetine hydrochloride using a DOE approach","volume":"11","author":"Shah","year":"2017","journal-title":"J Taibah Univ Sci"},{"key":"10.1016\/j.pharma.2023.07.008_bib0140","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1556\/1326.2021.00926","article-title":"High performance thin layer chromatography (HPTLC) method development and validation for determination of doxycycline hyclate in capsule and tablet formulations","volume":"34","author":"Kumssa","year":"2022","journal-title":"Acta Chromatogr"},{"key":"10.1016\/j.pharma.2023.07.008_bib0145","doi-asserted-by":"crossref","first-page":"684369","DOI":"10.4061\/2011\/684369","article-title":"Development and validation of HPTLC method for estimation of carbamazepine in formulations and its in vitro release study","volume":"2011","author":"Patel","year":"2011","journal-title":"Chromatogr Res Int"},{"key":"10.1016\/j.pharma.2023.07.008_bib0150","doi-asserted-by":"crossref","first-page":"109800","DOI":"10.1016\/j.msec.2019.109800","article-title":"Improved bioavailability of azelnidipine gastro retentive tablets\u00a0\u2013\u00a0optimization and in-vivo assessment","volume":"103","author":"Gaikwad","year":"2019","journal-title":"Mater Sci Eng C"},{"key":"10.1016\/j.pharma.2023.07.008_bib0155","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1081\/DDC-100102248","article-title":"The influence of \u03b2-cyclodextrin on the solubility of chlorthalidone and its enantiomers","volume":"25","author":"L\u00f6tter","year":"1999","journal-title":"Drug Dev Ind Pharm"},{"key":"10.1016\/j.pharma.2023.07.008_bib0160","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.chroma.2007.03.057","article-title":"An unexpected observation concerning the effect of anionic additives on the retention behavior of basic drugs and peptides in reversed-phase liquid chromatography","volume":"1154","author":"Wang","year":"2007","journal-title":"J Chromatogr A"},{"key":"10.1016\/j.pharma.2023.07.008_bib0165","doi-asserted-by":"crossref","first-page":"S3426","DOI":"10.1016\/j.arabjc.2014.02.002","article-title":"Spectrophotometric determination of chlorthalidone in pharmaceutical formulations using different order derivative methods","volume":"10","author":"Narmeen","year":"2017","journal-title":"Arab J Chem"},{"key":"10.1016\/j.pharma.2023.07.008_bib0170","doi-asserted-by":"crossref","first-page":"541","DOI":"10.3797\/scipharm.1312-14","article-title":"Validated stability-indicating RP-HPLC method for the simultaneous determination of azelnidipine and olmesartan in their combined dosage form","volume":"82","author":"Patel","year":"2014","journal-title":"Sci Pharm"}],"container-title":["Annales Pharmaceutiques Fran\u00e7aises"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003450923000779?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003450923000779?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T23:39:15Z","timestamp":1757720355000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003450923000779"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S0003450923000779"],"URL":"https:\/\/doi.org\/10.1016\/j.pharma.2023.07.008","relation":{},"ISSN":["0003-4509"],"issn-type":[{"type":"print","value":"0003-4509"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Separation and quantification of azelnidipine and chlorthalidone in a synthetic mixture using optimized HPTLC method","name":"articletitle","label":"Article Title"},{"value":"Annales Pharmaceutiques Fran\u00e7aises","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharma.2023.07.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Acad\u00e9mie Nationale de Pharmacie. Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}